Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
UPC stock price ended at $2.73 on 金曜日, after rising 16.67%
On the latest trading day Mar 27, 2026, the stock price of UPC rose by 16.67%, climbing from $2.50 to $2.73. During the session, the stock saw a volatility of 31.20%, with prices oscillating between a daily low of $2.50 and a high of $3.28. Notably, trading volume dropped by 16.1K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 20.1K shares were traded, equating to a market value of approximately $1.5M.